Role of ß Blockers in Congestive Heart Failure
Open Access
- 1 November 2000
- journal article
- Published by Wiley in Congestive Heart Failure
- Vol. 6 (6), 299-312
- https://doi.org/10.1111/j.1527-5299.2000.80176.x
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The effects of norepinephrine on myocardial biology: Implications for the therapy of heart failureClinical Cardiology, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureThe New England Journal of Medicine, 1996
- Early reduction of neurohumoral factors plays a key role in mediating the efficacy of β-blocker therapy for congestive heart failureAmerican Heart Journal, 1996
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Angiotensin II (AII)-Induced Myocyte Necrosis: Role of the AII ReceptorJournal of Cardiovascular Pharmacology, 1994
- Neurohumoral activation in congestive heart failureAmerican Heart Journal, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureThe New England Journal of Medicine, 1986
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureThe New England Journal of Medicine, 1984
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981